Drug Type Small molecule drug |
Synonyms BBP, Betamethasone butyrate propionate (JAN), TO 186 + [3] |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (03 Jan 1995), |
Regulation- |
Molecular FormulaC29H39FO7 |
InChIKeyVXOWJCTXWVWLLC-REGDIAEZSA-N |
CAS Registry5534-02-1 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Psoriasis | Japan | - | 03 Jan 1995 |
| Cicatrix, Hypertrophic | - | - | - |
| Dermatitis | - | - | - |
| Eczema | - | - | - |
| Erythema | - | - | - |
| Exanthema | - | - | - |
| Keratosis, Seborrheic | - | - | - |
| Lichen Planus | - | - | - |
| Lupus Erythematosus, Discoid | - | - | - |
| Mycosis Fungoides | - | - | - |
| Pemphigoid, Bullous | - | - | - |
| Prurigo | - | - | - |
| Sarcoidosis | - | - | - |





